MedMira Inc. MMIRF
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 322.84% | -63.58% | -13.50% | -21.66% | -30.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 322.84% | -63.58% | -13.50% | -21.66% | -30.78% |
| Cost of Revenue | 14.74% | -12.00% | -20.77% | -13.82% | -12.17% |
| Gross Profit | 107.44% | -10.27% | 23.18% | 11.34% | 1.69% |
| SG&A Expenses | -23.13% | -66.95% | -19.01% | -34.77% | 13.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.50% | -62.21% | -43.16% | -18.52% | 10.01% |
| Operating Income | 62.37% | 62.12% | 44.89% | 18.28% | -15.53% |
| Income Before Tax | 49.01% | 43.84% | 38.48% | 11.75% | -20.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 49.01% | 43.84% | 38.48% | 11.75% | -20.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.01% | 43.84% | 38.48% | 11.75% | -20.35% |
| EBIT | 62.37% | 62.12% | 44.89% | 18.28% | -15.53% |
| EBITDA | 69.70% | 66.69% | 47.93% | 18.51% | -13.20% |
| EPS Basic | 50.00% | 41.67% | 42.86% | 8.33% | -25.00% |
| Normalized Basic EPS | 50.00% | 50.00% | 37.50% | 12.50% | -20.00% |
| EPS Diluted | 30.00% | 50.00% | 46.67% | 26.67% | -25.00% |
| Normalized Diluted EPS | 50.00% | 50.00% | 37.50% | 12.50% | -20.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 1.06% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 1.06% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |